Page 17 - Hospital Authority Annual Report 2019-2020

Since the COVID-19 outbreak in early 2020, the HA 2019冠狀病毒病於2020年初來襲，醫管局
Board, in accordance with HA’s Emergency Contingency 大會迅速肩負領導及監察的角色，根據醫
Plan, swiftly convened Emergency Executive Committee 管局緊急應變計劃召開緊急應變策導委員
meetings to steer strategies and actions in combating 會會議，督導抗疫策略及工作。醫管局
the disease and monitor the latest situation. Being 全體員工以市民福祉為先，眾志成城、
united behind the same goal to protect the people of 不辭勞苦參與各項抗疫工作，盡力遏止病
Hong Kong, the entire HA has demonstrated strenuous 毒在社區擴散，保障全港市民健康，對此
efforts in fi ghting the disease with profound endurance, 我深以為傲。
professionalism and commitment. I take pride in this.

The HKSAR Government’s unfaltering support is no doubt 醫管局面對著各項挑戰，有賴香港特區政
our reliable backup so that we can rise above all challenges 府在政策及財政上長期不懈作出支持。即
and emerge even stronger. Regardless of the economic 使在經濟下行壓力下，政府亦按照承諾，
downturn pressure, the commitment of the Government 繼續按三年為一周期的遞增撥款安排，在
continues to sustain the development of public healthcare, 2019-20年度增加對醫管局的經常撥款8%
with 8% increase in recurrent financial provision to a 至688億元，充份表達對公營醫療發展的
total of $68.8 billion in 2019-20 to HA under the triennial 承擔。在疫情期間，政府更從防疫抗疫
progressive recurrent funding arrangement. In particular,
the Government has provided additional funding allocation 基金額外撥款47億元予醫管局對抗2019
of $4.7 billion from the Anti-epidemic Fund to HA, enabling 冠狀病毒病疫情。我們善用資源於增加前
us to strengthen frontline manpower resources, equip 線醫護人員的相關開支、增購個人保護裝
additional personal protective equipment, and enhance 備及加強化驗室支援等方面，以提升公立
laboratory support, etc., in order to build up the capability 醫院應對疫情的能力。
to respond to the COVID-19 outbreak.

Chairman’s Review 主席匯報 15